Company Performance Metrics
Servier Ukraine markets and distributes prescription medicines developed by the Servier Group across cardiometabolic, venous, oncologic and neurologic therapeutic areas. The company focuses on original brands used in conditions such as arterial hypertension, diabetes, venous disease, angina and certain cancers. It provides information on its
medicines to healthcare professionals and patients in line with Ukrainian regulation and does not offer diagnostic or treatment advice. Servier Ukraine operates pharmacovigilance and medical information channels to collect safety reports and product quality inquiries. It also conducts educational and awareness initiatives for physicians and patients related to cardiovascular disease and diabetes, and participates in partnerships and programs in the healthcare sector.